ACE inhibitors are routinely given for the treatment of hypertension and renal dysfunction in systemic lupus erythematosus (SLE) patients, despite the fact that no randomised controlled studies have been conducted [39]. The gene discussed is ACE; the disease is hypertensive disorder.